Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Amber Draper"'
Autor:
Haydn Kissick, Viraj A Master, Mehmet A Bilen, Zachary S Buchwald, Mohammad K Khan, Caroline S Jansen, Michael C Lowe, Jimmy S Patel, Yena Woo, Amber Draper, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, David C Qian
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Recent studies have demonstrated that earlier time-of-day infusion of immune checkpoint inhibitors (ICIs) is associated with longer progression-free survival (PFS) and overall survival (OS) among patients with metastatic melanoma and non-s
Externí odkaz:
https://doaj.org/article/daa2d9d9173340d48a63f3613635074f
Autor:
Kenneth H. Yu, Andrew E. Hendifar, Olatunji B. Alese, Amber Draper, Maen Abdelrahim, Ethan Burns, Gazala Khan, Paul Cockrum, Rachel H. Bhak, Catherine Nguyen, Maral DerSarkissian, Mei Sheng Duh, Nathan Bahary
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe NAPOLI-1 trial demonstrated that liposomal irinotecan in combination with fluorouracil (5-FU) and leucovorin (LV) prolonged survival with a manageable safety profile in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) p
Externí odkaz:
https://doaj.org/article/43a57f71459e47a9b5b2ba864581164f
Autor:
Amber Draper, Emily H. Jung, Yichun Cao, Rami P. Atallah, Jeffrey Switchenko, Sujata Kane, Jessica Guadagno, Aaron T. Jones, Edith Brutcher, Olatunji B. Alese
Publikováno v:
Oncology. 101:213-223
Introduction: Checkpoint inhibitors (CPI) have significantly improved survival among patients with various cancer types. Prior studies have shown a correlation between immune cell infiltration and poorly differentiated cancers. This study evaluated t
Autor:
Sandra Kang, Lana Khalil, Ashley McCook‐Veal, Yuan Liu, John Galvin, Amber Draper, Nima Kokabi, Maria Diab, Walid Shaib, Olatunji Alese, Olumide Gbolahan, Bassel El‐Rayes, Mehmet Akce
Publikováno v:
Liver Cancer International.
Autor:
Mohammed B. Allaw, Jeffrey M. Switchenko, Lana Khalil, Christina Wu, Olatunji B. Alese, Mehmet Akce, Amber Draper, Aaron T. Jones, Bassel El-Rayes, Walid Shaib
Publikováno v:
Oncology
Background: The 2 approved somatostatin analogs (SSAs) in the first-line treatment of advanced, well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are octreotide long-acting release (Sandostatin LAR) and somatuline depot (Lan
Autor:
Sandra Kang, Joseph Magliocca, Marty Sellers, Giorgio Roccaro, Wei Zheng, Melina Pectasides, Amber Draper, Jessica Guadagno, Bassel El-Rayes, Mehmet Akce
Publikováno v:
Oncology Research and Treatment. 45:430-437
Introduction: Fibrolamellar carcinoma (FLC) is a rare liver cancer that predominantly affects younger patients without a history of liver disease. Surgical resection is the cornerstone of therapy and represents the best potentially curative treatment
Autor:
Jimmy Patel, Amber Draper, Yena Woo, Layla Dhabaan, Pretesh Patel, Ashesh Jani, Bradley Carthon, Viraj Master, Haydn Kissick, Mehmet Bilen, Zachary Buchwald, David Qian
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Kristen K. Ciombor, Yoanna Pumpalova, Christina Wu, Tanios Bekaii-Saab, Mohamad Bassam Sonbol, Jordan Berlin, Gregory B. Lesinski, Zhengjia Chen, Bassel F. El-Rayes, Ibrahim Halil Sahin, Amber Draper, Subir Goyal, Sigurdis Haraldsdottir, Satya Das, Daniel H. Ahn
Publikováno v:
Oncologist
Background Immune checkpoint inhibitor (ICI) therapy is highly effective in metastatic mismatch repair-deficient (MMR-D) colorectal cancer (CRC). In this study, we evaluated molecular and clinical predictors of ICI response in MMR-D CRC. Materials an
Autor:
Maen Abdelrahim, Rachel H. Bhak, Mei Sheng Duh, Olatunji B. Alese, Amber Draper, Ethan Burns, Maral DerSarkissian, Nathan Bahary, Gazala Khan, Andrew Eugene Hendifar, Kenneth H. Yu, Catherine Nguyen, Paul Cockrum
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundThe NAPOLI-1 trial demonstrated that liposomal irinotecan in combination with fluorouracil (5-FU) and leucovorin (LV) prolonged survival with a manageable safety profile in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) p
Autor:
Lana Khalil, Sandra Kang, Ashley McCook-Veal, Amber Draper, Maria Diab, Walid Labib Shaib, Olatunji B. Alese, Bassel F. El-Rayes, Mehmet Akce
Publikováno v:
Journal of Clinical Oncology. 40:4118-4118
4118 Background: Non-alcoholic steatohepatitis (NASH) is an emerging etiology for hepatocellular carcinoma (HCC) and contributes to the increasing incidence of HCC worldwide. Patients with NASH often have risk factors of metabolic syndrome including